We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
10 hedge funds and large institutions have $768K invested in Plus Therapeutics in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
9% less funds holding
Funds holding: 11 → 10 (-1)
12% less capital invested
Capital invested by funds: $875K → $768K (-$107K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$162K |
| 2 |
Two Sigma Investments
New York
|
+$91.5K |
| 3 |
Two Sigma Advisers
New York
|
+$56.4K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$31.6K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.7K |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$166K |
| 2 |
Bank of New York Mellon
New York
|
-$79K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$23.1K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$23K |
| 5 |
VF
Virtu Financial
New York
|
-$7.7K |